189 related articles for article (PubMed ID: 29228029)
1. Pockets as structural descriptors of EGFR kinase conformations.
Hasenahuer MA; Barletta GP; Fernandez-Alberti S; Parisi G; Fornasari MS
PLoS One; 2017; 12(12):e0189147. PubMed ID: 29228029
[TBL] [Abstract][Full Text] [Related]
2. Dynamics fingerprints of active conformers of epidermal growth factor receptor kinase.
Barletta GP; Hasenahuer MA; Fornasari MS; Parisi G; Fernandez-Alberti S
J Comput Chem; 2018 Nov; 39(29):2472-2480. PubMed ID: 30298935
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation.
Tamirat MZ; Koivu M; Elenius K; Johnson MS
PLoS One; 2019; 14(9):e0222814. PubMed ID: 31536605
[TBL] [Abstract][Full Text] [Related]
4. Effects of oncogenic mutations on the conformational free-energy landscape of EGFR kinase.
Sutto L; Gervasio FL
Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10616-21. PubMed ID: 23754386
[TBL] [Abstract][Full Text] [Related]
5. Transitions to catalytically inactive conformations in EGFR kinase.
Shan Y; Arkhipov A; Kim ET; Pan AC; Shaw DE
Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7270-5. PubMed ID: 23576739
[TBL] [Abstract][Full Text] [Related]
6. Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain.
Park JH; Liu Y; Lemmon MA; Radhakrishnan R
Biochem J; 2012 Dec; 448(3):417-23. PubMed ID: 23101586
[TBL] [Abstract][Full Text] [Related]
7. Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors.
Macdonald-Obermann JL; Pike LJ
J Biol Chem; 2018 Aug; 293(35):13401-13414. PubMed ID: 29997256
[TBL] [Abstract][Full Text] [Related]
8. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
9. Computational study of EGFR inhibition: molecular dynamics studies on the active and inactive protein conformations.
Songtawee N; Gleeson MP; Choowongkomon K
J Mol Model; 2013 Feb; 19(2):497-509. PubMed ID: 22955422
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3.
Jura N; Shan Y; Cao X; Shaw DE; Kuriyan J
Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21608-13. PubMed ID: 20007378
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor.
Mi LZ; Lu C; Li Z; Nishida N; Walz T; Springer TA
Nat Struct Mol Biol; 2011 Aug; 18(9):984-9. PubMed ID: 21822280
[TBL] [Abstract][Full Text] [Related]
12. The antibody zalutumumab inhibits epidermal growth factor receptor signaling by limiting intra- and intermolecular flexibility.
Lammerts van Bueren JJ; Bleeker WK; Brännström A; von Euler A; Jansson M; Peipp M; Schneider-Merck T; Valerius T; van de Winkel JG; Parren PW
Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6109-14. PubMed ID: 18427122
[TBL] [Abstract][Full Text] [Related]
13. Visualisation of variable binding pockets on protein surfaces by probabilistic analysis of related structure sets.
Ashford P; Moss DS; Alex A; Yeap SK; Povia A; Nobeli I; Williams MA
BMC Bioinformatics; 2012 Mar; 13():39. PubMed ID: 22417279
[TBL] [Abstract][Full Text] [Related]
14. Effect of carboxyl terminal truncation on the tyrosine kinase activity of the epidermal growth factor receptor.
Wedegaertner PB; Gill GN
Arch Biochem Biophys; 1992 Jan; 292(1):273-80. PubMed ID: 1309297
[TBL] [Abstract][Full Text] [Related]
15. Comparison of conservation within and between the Ser/Thr and Tyr protein kinase family: proposed model for the catalytic domain of the epidermal growth factor receptor.
Singh J
Protein Eng; 1994 Jul; 7(7):849-58. PubMed ID: 7971947
[TBL] [Abstract][Full Text] [Related]
16. Atomistic insights into regulatory mechanisms of the HER2 tyrosine kinase domain: a molecular dynamics study.
Telesco SE; Radhakrishnan R
Biophys J; 2009 Mar; 96(6):2321-34. PubMed ID: 19289058
[TBL] [Abstract][Full Text] [Related]
17. Conformation of the transmembrane domain of the epidermal growth factor receptor.
Brandt-Rauf PW; Monaco R; Pincus MR
J Protein Chem; 1994 Feb; 13(2):227-31. PubMed ID: 7914727
[TBL] [Abstract][Full Text] [Related]
18. Co-conserved features associated with cis regulation of ErbB tyrosine kinases.
Mirza A; Mustafa M; Talevich E; Kannan N
PLoS One; 2010 Dec; 5(12):e14310. PubMed ID: 21179209
[TBL] [Abstract][Full Text] [Related]
19. Computational delineation of tyrosyl-substrate recognition and catalytic landscapes by the epidermal growth factor receptor tyrosine kinase domain.
Liu Y; Radhakrishnan R
Mol Biosyst; 2014 Jul; 10(7):1890-904. PubMed ID: 24779031
[TBL] [Abstract][Full Text] [Related]
20. Coarse-grained molecular simulation of epidermal growth factor receptor protein tyrosine kinase multi-site self-phosphorylation.
Koland JG
PLoS Comput Biol; 2014 Jan; 10(1):e1003435. PubMed ID: 24453959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
